In breast cancer cells, E-cadherin downregulation hyperactivates IGF1R/IR signaling, thus enhancing sensitivity of breast cancer cells to IGF1 stimulation and Akt or ERK phosphorylation [4,157]. The gene discussed is CDH1; the disease is breast carcinoma.